Purpose Mutations in the epidermal growth factor receptor (EGFR) gene have been
identified as potential targets for the treatment and prognostic factors for non-small cell lung …

Purpose. To compare 18F‐fluorodeoxyglucose positron emission tomography (FDG‐PET)
and computed tomography (CT) imaging characteristics in non‐small cell lung cancer …

Objective Epidermal growth factor receptor (EGFR) mutations in lung adenocarcinoma are
involved in the tumorigenesis and regulation of cell metabolism via Akt signaling. F-18 …

This retrospective study was performed to evaluate a possible association between the
presence of epidermal growth factor receptor (EGFR) mutations and the standardized …

Purpose The identification of the mutation status of the epidermal growth factor receptor
(EGFR) is important for the optimization of treatment in patients with pulmonary …

Background EGFR mutation-induced cell proliferation causes changes in tumor biology and
tumor metabolism, which may reflect tumor marker concentration and 18F-FDG uptake on …

Background A non-invasive, simple, and convenient method to evaluate the presence of
epidermal growth factor receptor (EGFR) mutations is important for initial treatment decisions …

Epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
are a response to EGFR-tyrosine kinase inhibitor. However, a lack of sufficient tumor tissue …

Background The purpose of this study was to investigate an association between EGFR
mutation status and 18F‐fluorodeoxyglucose positron emission tomography‐computed …

The study aimed to explore the correlation of epidermal growth factor receptor (EGFR)
mutation with tumor node metastasis (TNM) stage in patients with non-small-cell lung cancer …